Correlation Between Discover Financial and Mink Therapeutics
Can any of the company-specific risk be diversified away by investing in both Discover Financial and Mink Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Discover Financial and Mink Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Discover Financial Services and Mink Therapeutics, you can compare the effects of market volatilities on Discover Financial and Mink Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Discover Financial with a short position of Mink Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Discover Financial and Mink Therapeutics.
Diversification Opportunities for Discover Financial and Mink Therapeutics
0.48 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Discover and Mink is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Discover Financial Services and Mink Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mink Therapeutics and Discover Financial is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Discover Financial Services are associated (or correlated) with Mink Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mink Therapeutics has no effect on the direction of Discover Financial i.e., Discover Financial and Mink Therapeutics go up and down completely randomly.
Pair Corralation between Discover Financial and Mink Therapeutics
Considering the 90-day investment horizon Discover Financial Services is expected to under-perform the Mink Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Discover Financial Services is 5.07 times less risky than Mink Therapeutics. The stock trades about -0.01 of its potential returns per unit of risk. The Mink Therapeutics is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest 528.00 in Mink Therapeutics on December 25, 2024 and sell it today you would earn a total of 329.00 from holding Mink Therapeutics or generate 62.31% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Discover Financial Services vs. Mink Therapeutics
Performance |
Timeline |
Discover Financial |
Mink Therapeutics |
Discover Financial and Mink Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Discover Financial and Mink Therapeutics
The main advantage of trading using opposite Discover Financial and Mink Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Discover Financial position performs unexpectedly, Mink Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mink Therapeutics will offset losses from the drop in Mink Therapeutics' long position.Discover Financial vs. Ally Financial | Discover Financial vs. Synchrony Financial | Discover Financial vs. Western Union Co | Discover Financial vs. Bread Financial Holdings |
Mink Therapeutics vs. Affimed NV | Mink Therapeutics vs. Adaptimmune Therapeutics Plc | Mink Therapeutics vs. Sangamo Therapeutics | Mink Therapeutics vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |